Published in

Taylor and Francis Group, Expert Opinion on Drug Discovery, 1(19), p. 9-20, 2023

DOI: 10.1080/17460441.2023.2267001

Links

Tools

Export citation

Search in Google Scholar

Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option

Journal article published in 2023 by Sara Ferraro, Irma Convertino ORCID, Emiliano Cappello, Giulia Valdiserra, Marco Bonaso, Marco Tuccori ORCID
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO